Search research articles
Contact Us
Filters
Showing results (161-170 of 216) with videos related to
Page
of 22
Sort By:
Molecular Imaging and Biology
|
August 24, 2010
Biodistribution and radiation dosimetry of the glycine transporter-1 ligand 11C-GSK931145 determined from primate and human whole-body PET
Santiago Bullich, Mark Slifstein, Jan Passchier, et al.
Nuclear Medicine and Biology
|
June 10, 1998
Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling
S Osman, C Lundkvist, V W Pike, et al.
Annals of Neurology
|
January 20, 2026
Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale
Zhen Fan, Graham Searle, Gaia Rizzo, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
November 4, 2008
Toward an improved prediction of human in vivo brain penetration
S G Summerfield, A J Lucas, R A Porter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2017
<sup>11</sup>C-PBR28 and <sup>18</sup>F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis
Gourab Datta, Alessandro Colasanti, Nicola Kalk, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 4, 2014
Relationship between glycine transporter 1 inhibition as measured with positron emission tomography and changes in cognitive performances in nonhuman primates
S A Castner, N V Murthy, K Ridler, et al.
Translational Psychiatry
|
July 20, 2021
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Ellis Chika Onwordi, Thomas Whitehurst, Ayla Mansur, et al.
Science Translational Medicine
|
September 6, 2019
In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury
Nikos Gorgoraptis, Lucia M Li, Alex Whittington, et al.
Journal of Geriatric Psychiatry and Neurology
|
May 1, 2010
Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls
D P Devanand, Arthur Mikhno, Gregory H Pelton, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 29, 2009
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studies
Idriss Bennacef, Cristian A Salinas, Thomas A Bonasera, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 216) with videos related to
Sort By:
Page
of 22
Molecular Imaging and Biology
|
August 24, 2010
Biodistribution and radiation dosimetry of the glycine transporter-1 ligand 11C-GSK931145 determined from primate and human whole-body PET
Santiago Bullich, Mark Slifstein, Jan Passchier, et al.
Nuclear Medicine and Biology
|
June 10, 1998
Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling
S Osman, C Lundkvist, V W Pike, et al.
Annals of Neurology
|
January 20, 2026
Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale
Zhen Fan, Graham Searle, Gaia Rizzo, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
November 4, 2008
Toward an improved prediction of human in vivo brain penetration
S G Summerfield, A J Lucas, R A Porter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2017
<sup>11</sup>C-PBR28 and <sup>18</sup>F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis
Gourab Datta, Alessandro Colasanti, Nicola Kalk, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 4, 2014
Relationship between glycine transporter 1 inhibition as measured with positron emission tomography and changes in cognitive performances in nonhuman primates
S A Castner, N V Murthy, K Ridler, et al.
Translational Psychiatry
|
July 20, 2021
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Ellis Chika Onwordi, Thomas Whitehurst, Ayla Mansur, et al.
Science Translational Medicine
|
September 6, 2019
In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury
Nikos Gorgoraptis, Lucia M Li, Alex Whittington, et al.
Journal of Geriatric Psychiatry and Neurology
|
May 1, 2010
Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls
D P Devanand, Arthur Mikhno, Gregory H Pelton, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 29, 2009
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studies
Idriss Bennacef, Cristian A Salinas, Thomas A Bonasera, et al.
Page
of 22